en

PRODUCT DETAIL

Hympavzi 150 mg injekčný roztok v naplnenom pere

Code 8203E
MA number EU/1/24/1874/002
Product Form: sol inj 1x1 ml/150 mg (pero napl.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
MAH, country: Pfizer Europe MA EEIG, Belgium
Therapeutic Class: 87 - VARIA I
ATC:
B BLOOD AND BLOOD FORMING ORGANS
B02 ANTIHEMORRHAGICS
B02B LOCAL HEMOSTATICS, COMBINATIONS
B02BX Other systemic hemostatics
B02BX11 Marstacimab
Shelf life: 24
Route of admin.: Subcutaneous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 18.11.2024
Validity: 18.11.2029
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 28.11.2024
eu-flag.png sk-flag.png